­
MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview
  • Bile Acids: A Novel Multiple Sclerosis Therapy?
  • Long-term HSCT Outcomes in Norway
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Q&A

Facebook Live

Taking The Opportunity To Talk

MStranslate
February 28, 2019
Community, Genetics, Q&A
Next week, we are holding another one of our Facebook Live Q&A sessions.  For this event, the theme will be genetics in multiple sclerosis.  It...

Google Hangout – Multiple Sclerosis Q&A

MStranslate
February 18, 2014
Research, Treatments
The first Google Hangout gave members of our community an opportunity to chat with MS researcher and MStranslate co-founder, Brett...

Recent Posts

  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview
  • Bile Acids: A Novel Multiple Sclerosis Therapy?

Recent Comments

  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS
  • Bile Acids: A Novel Multiple Sclerosis Therapy? on Bile Acids May Play Role in Multiple Sclerosis
  • MStranslate on Is Vitamin B12 Important in Multiple Sclerosis?
  • MStranslate on Facebook Live: Diet Outcomes in Multiple Sclerosis
  • A on Facebook Live: Diet Outcomes in Multiple Sclerosis

Calendar

April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« Mar    

Archives

  • March 2025
  • November 2024
  • October 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • December 2023
  • November 2023
  • October 2023
  • July 2023
  • March 2023
  • January 2023
  • November 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • March 2013
  • February 2013
  • December 2012
  • October 2012

Categories

  • AAN
  • ACTRIMS
  • Alemtuzumab
  • B Cells
  • Basic Sciences
  • Behind the Scenes
  • Biotin
  • Cambridge
  • CCSVI
  • Clinical Trials
  • Cognition
  • Collaboration
  • Community
  • Conferences
  • COVID-19
  • Daclizumab
  • Diet
  • Dimethyl fumarate
  • Dr Sally Shaw
  • Dr Travis Stiles
  • ECTRIMS
  • Epstein-Barr virus
  • Events
  • Exercise
  • Fatigue
  • Feedback
  • Fingolimod
  • Genetics
  • Google Hangouts
  • Gut microbiome
  • Hormones
  • Infection
  • Interferon-beta
  • Laquinimod
  • Lifestyle
  • Medicinal Cannabis
  • Mental Health
  • MIS416
  • Movement Disorders
  • MS Virtual
  • MS: Many Stories
  • MStranslate
  • Natalizumab
  • Neuroimaging
  • Ocrelizumab
  • Ocular Motor
  • Opinion
  • Podcasts
  • Presentations
  • Progressive MS
  • Q&A
  • Quality of Life
  • Recruitment
  • Rehabilitation
  • Remyelination
  • Research
  • Rituximab
  • Social Media
  • Stem Cells
  • Symposium
  • Symptoms
  • Treatments
  • Type 1 Diabetes
  • Uncategorized
  • Understanding Science
  • Videos
  • Vitamin B12
  • Vitamin D

Posts

  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview
  • Bile Acids: A Novel Multiple Sclerosis Therapy?

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkValues & Standards